LABT — Lakewood-amedex Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Lakewood-amedex Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.39	0.681	0.236
Prepaid Expenses
Total Current Assets	6.48	0.774	0.305
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.405	0.288	0.168
Other Long Term Assets
Total Assets	6.89	1.07	0.482
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	2.06	0.501	2.41
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.34	0.661	2.45
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	4.56	0.41	-1.96
Total Liabilities & Shareholders' Equity	6.89	1.07	0.482
Total Common Shares Outstanding